Compounds and methods are provided for modulating in vitro and in vivo
processes mediated by selectin binding. More specifically, selectin
modulators and their use are described, wherein the selectin modulators
that modulate (e.g., inhibit or enhance) a selectin-mediated function
comprise particular glycomimetics alone or linked to a member of a class
of compounds termed BASAs (Benzyl Amino Sulfonic Acids) or a member of a
class of compounds termed BACAs (Benzyl Amino Carboxylic Acids).